ibritumomab tiuxetan 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
chelating agents	4984	206181-63-7

Description:

Molecule	Description
Synonyms: ibritumomab tiuxetan (90Y) ibritumomab tiuxetan zevalin IDEC-Y2B8	90Y-labeled anti-CD20 monoclonal antibody for radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma Molecular weight: 660.50 Formula: C23H32N5O10SY CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Molecule

Description

Synonyms:

ibritumomab tiuxetan (90Y)
ibritumomab tiuxetan
zevalin
IDEC-Y2B8

90Y-labeled anti-CD20 monoclonal antibody for radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma

Molecular weight: 660.50
Formula: C23H32N5O10SY
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA:
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
Feb. 19, 2002	FDA	SPECTRUM PHARMS
Jan. 16, 2004	EMA

FDA Adverse Event Reporting System (Female)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Thrombocytopenia	99.64	37.68	50	1084	151107	63336781
Bone marrow failure	92.38	37.68	30	1104	29260	63458628
Progressive multifocal leukoencephalopathy	78.62	37.68	22	1112	12949	63474939
Stem cell transplant	71.02	37.68	14	1120	1808	63486080
Myelodysplastic syndrome	68.76	37.68	21	1113	16733	63471155
Neutropenia	50.70	37.68	34	1100	174971	63312917
Enterococcal infection	41.60	37.68	12	1122	7836	63480052
Pancytopenia	41.05	37.68	24	1110	96909	63390979

Showing 1 to 8 of 8 entries

Previous1Next

FDA Adverse Event Reporting System (Male)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Myelodysplastic syndrome	92.91	36.77	34	1500	19174	34936223
Meningitis tuberculous	90.87	36.77	17	1517	668	34954729
Mucosal inflammation	58.17	36.77	30	1504	38592	34916805
Venoocclusive liver disease	53.40	36.77	18	1516	7948	34947449
Herpes simplex	51.26	36.77	16	1518	5543	34949854
Progressive multifocal leukoencephalopathy	49.81	36.77	18	1516	9746	34945651
Acute myeloid leukaemia	48.51	36.77	21	1513	18249	34937148
Bone marrow failure	44.81	36.77	23	1511	29230	34926167
Thrombocytopenia	43.24	36.77	43	1491	156204	34799193
Stem cell transplant	36.81	36.77	10	1524	2129	34953268

Showing 1 to 10 of 10 entries

Previous1Next

FDA Adverse Event Reporting System (Geriatric)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Myelodysplastic syndrome	134.83	31.59	47	2615	30254	79711472
Bone marrow failure	114.29	31.59	48	2614	51059	79690667
Progressive multifocal leukoencephalopathy	107.41	31.59	36	2626	20564	79721162
Thrombocytopenia	97.10	31.59	76	2586	265183	79476543
Stem cell transplant	92.20	31.59	22	2640	3682	79738044
Meningitis tuberculous	79.86	31.59	16	2646	1189	79740537
Cytomegalovirus infection	69.20	31.59	32	2630	42612	79699114
Neutropenia	65.64	31.59	63	2599	287647	79454079
Pancytopenia	63.77	31.59	49	2613	165696	79576030
Platelet count decreased	63.04	31.59	52	2610	194612	79547114

Showing 1 to 10 of 25 entries

Previous1 2 3Next

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Show entries

Search:

Source	Code	Description
ATC	V10XX02	VARIOUS THERAPEUTIC RADIOPHARMACEUTICALS OTHER THERAPEUTIC RADIOPHARMACEUTICALS Various therapeutic radiopharmaceuticals
FDA EPC	N0000175658	CD20-directed Radiotherapeutic Antibody
FDA MoA	N0000000205	Radiopharmaceutical Activity
FDA MoA	N0000175078	CD20-directed Antibody Interactions

Showing 1 to 4 of 4 entries

Previous1Next

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Follicular non-Hodgkin's lymphoma	indication	308121000

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Show entries

Search:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
B-lymphocyte antigen CD20	Surface antigen	P11836	CD20_HUMAN	ANTIBODY BINDING	Kd	7.85		DRUG LABEL	DRUG LABEL

Showing 1 to 1 of 1 entries

Previous1Next

External reference:

Show entries

Search:

ID	Source
009576	NDDF
17128	MMSL
262323	RXNORM
385546007	SNOMEDCT_US
385548008	SNOMEDCT_US
4021301	VUID
4021301	VANDF
4Q52C550XK	UNII
6777	IUPHAR_LIGAND_ID
74890578	PUBCHEM_CID

Showing 1 to 10 of 19 entries

Previous1 2Next

Pharmaceutical products:

None